Variants of SLC39A8 are associated with a shift in gut microbiome composition, T cell immunity, lipid levels, blood pressure, and obesity, highlighting the relationship between schizophrenia, inflammation, and metabolic dysregulation (Marger et al., 2014; Li et al., 2016). The gene discussed is SLC39A8; the disease is schizophrenia.